Leaflet PNEUMOXON 0.25% / 10% compressed medicinal gas

Product code:
W69781001
Indicated for:
pulmonary function testing
Route of administration:
inhalation
Substance:
carbon monoxide + helium (diagnostic respiratory gases)
ATC
V03AN — Various | All other therapeutic products | All other therapeutic products | Medical gases
Carbon monoxide combined with helium is used in pulmonary diffusion tests to assess the lungs' ability to transfer oxygen from inhaled air into the bloodstream. This gas mixture is inhaled by the patient during the test, and the concentrations of carbon monoxide and helium are measured to calculate gas exchange efficiency.

The pulmonary diffusion test is essential for diagnosing and monitoring lung diseases such as pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. Carbon monoxide is used in very small, safe amounts for the patient, while helium serves as a reference gas.

The procedure is non-invasive and takes only a few minutes. The patient must follow the doctor's instructions, which include deep breathing and holding their breath for a few seconds. The test results provide valuable information about lung function.

Side effects are rare but may include dizziness or temporary discomfort. It is important for patients to inform their doctor of any pre-existing conditions or breathing difficulties before the test.

General data about PNEUMOXON 0.25% / 10%

Substance:
carbon monoxide + helium
Product code:
W69781001
Concentration:
0.25% / 10%
Pharmaceutical form:
compressed medicinal gas
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
MESSER AUSTRIA GMBH - AUSTRIA
Holder:
MESSER ROMANIA GAZ S.R.L. - ROMANIA
Number:
15143/2023/01
Shelf life:
2 years

Concentrations available for carbon monoxide + helium

  • 0.25%/10%
  • 0.25%/18%